Overnight Digest- Stocks to look out for on February 6
DSIJ Intelligence / 03 Feb 2017
The stocks which could witness significant movement on February 6 are Jagran Prakashan, Jindal Steel & Power/Adani Power, Bharat Forge, Lupin, Vakrangee, Dr Reddys Laboratories, Jammu and Kashmir Bank.
The stocks which could witness significant movement on February 6 are Jagran Prakashan, Jindal Steel & Power/Adani Power, Bharat Forge, Lupin, Vakrangee, Dr Reddys Laboratories, Jammu and Kashmir Bank.
Jagran Prakashan: Music Broadcast, subsidiary of Jagran Prakashan, has commenced broadcast from its radio station at Kolhapur with frequency at 95 F.M. The share price of the company will be watched on Monday.
Jindal Steel & Power/Adani Power: Jindal Steel & Power (JSPL) is likely to be in talks to sell power plant to Adani Power and others for USD 1.5 billion.
Bharat Forge: Bharat Forge has divested its entire stake in its wholly-owned subsidiary Kalyani Polytechnic w.e.f. February 3. The share price of the company will remain in focus on Monday.
Lupin: Lupin has received FDA approval for Triamcinolone Acetonide cream. The share price of Lupin will remain in limelight on February 6.
Vakrangee, Dr Reddy's Laboratories, Jammu and Kashmir Bank: Vakrangee, Dr Reddy's Laboratories and Jammu and Kashmir Bank will declare their results over the weekend. The share price of these companies will remain in focus on Monday.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.